BV-6

製品コードS7597 バッチS759702

印刷

化学情報

 Chemical Structure Synonyms N/A Storage
(From the date of receipt)
3 years -20°C powder
1 years -80°C in solvent
化学式

C70H96N10O8.xCF3COOH

分子量 1205.57 CAS No. 1001600-56-1(freebase)
Solubility (25°C)* 体外 DMSO 100 mg/mL (82.94 mM)
Water 100 mg/mL (82.94 mM)
Ethanol 100 mg/mL warmed with 50ºC water bath (82.94 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液(一定の濃度)を調合する

生物活性

製品説明 BV-6 is a SMAC mimetic, dual cIAP and XIAP inhibitor.
in vitro

BV6 inhibits the cell viability of HCC193 NSCLC cells with IC50 of 7.2 μM, induces apoptosis in both HCC193 and H460 cell lines, and also significantly enhances the radiosensitivity of these cell lines through activation of cleaved caspase-8 and cleaved caspase-9, respectively. [1]

In immature dendritic cells, BV-6 treatment results in moderate activation of the classical NF-kB pathway. [2]

Furthermore, BV-6 increases CIK cell-mediated lysis of hematological (H9, THP-1, and Tanoue) and solid malignancies (RH1, RH30, and TE671). BV-6 also enhances apoptosis of peripheral blood mononuclear cells and most notably has an inhibitory effect on immune cells limiting their cytotoxic potential. [3]

in vivo

BV6 is an IAP antagonist.

プロトコル(参考用のみ)

細胞アッセイ 細胞株 HCC193 and H460 cells
濃度 ~30 μM
反応時間 ~48 hours
実験の流れ

Cell viability is measured using the CellTiter 96® Aqueous Non-Radioactive Cell Proliferation Assay kit. 5000 cells/well are seeded into 96-well plates in triplicate. Following adhesion of cells to the wells, increasing concentrations of BV6 are added into different wells. Control groups are exposed to the same concentration of DMSO. The final concentrations of 333 μg/mL MTS and 25 μM PMS are added to each well 24 hours later. After two hours incubation at 37 °C in humidified 5% CO2, plates are read at the absorbance of 490-nm on a microplate reader. Relative cell viability of an individual sample is calculated by normalizing their absorbance to that of the corresponding control. IC50 values are calculated using Prism 5.01. For the TNFα neutralizing antibody assay, cells are exposed to 1 and 5 μM BV6 with or without 10 μg/mL infliximab and the assay is performed 24 hours later. Plates are read at the absorbance of 490-nm on a microplate reader

動物実験 動物モデル Female BALB/c mice
投薬量 10 mg/kg
投与方法 i.p.

カスタマーフィードバック

, , FASEB J, 2017, 31(11):4707-4719

Data from [Data independently produced by , , Clin Cancer Res, 2018, doi:10.1158/1078-0432.CCR-18-1548]

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells [ Cell Rep Med, 2024, 5(1):101377] PubMed: 38232703
IE1 of Human Cytomegalovirus Inhibits Necroptotic Cell Death via Direct and Indirect Modulation of the Necrosome Complex [ Viruses, 2024, 16(2)290] PubMed: 38400065
Phase separation of FSP1 promotes ferroptosis [ Nature, 2023, 619(7969):371-377] PubMed: 37380771
Telomere-to-mitochondria signalling by ZBP1 mediates replicative crisis [ Nature, 2023, 614(7949):767-773] PubMed: 36755096
Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist [ Cell Death Dis, 2023, 14(8):555] PubMed: 37620300
RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models [ Cells, 2023, 12(3)417] PubMed: 36766759
Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis [ Cancers (Basel), 2023, 15(3)967] PubMed: 36765925
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects [ Sci Adv, 2023, 9(33):eadf6692] PubMed: 37595047
SREBP activation contributes to fatty acid accumulations in necroptosis [ RSC Chem Biol, 2023, 4(4):310-322] PubMed: 37034406
ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation [ Nature, 2022, 607(7920):784-789] PubMed: 35859175

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。